NovaBridge Biosciences American Depositary Shares
NBP
28 hedge funds and large institutions have $17.6M invested in NovaBridge Biosciences American Depositary Shares in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 13 closing their positions.
900% more call options, than puts
Call options by funds: $70K | Put options by funds: $7K
0.51% less ownership
Funds ownership: 8.14% → 7.63% (-0.51%)
26% less funds holding
Funds holding: 38 → 28 (-10)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
31% less capital invested
Capital invested by funds: $25.3M → $17.6M (-$7.73M)
77% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CP
Caligan Partners
New York
|
+$156K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$74.7K |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$49.7K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$31.5K |
| 5 |
Morgan Stanley
New York
|
+$21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$455K |
| 2 |
EAM
Exome Asset Management
New York
|
-$453K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$453K |
| 4 |
State Street
Boston,
Massachusetts
|
-$172K |
| 5 |
Two Sigma Advisers
New York
|
-$96.8K |
NBP Hedge Fund Activity: Q3 2024 in Review
28 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q3 2024, worth a combined $17.6M — down 31% from $25.3M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of NBP and 3 opened new positions — a net loss of 10 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was Caligan Partners, adding an estimated $156K. The largest seller was GSA Capital Partners, exiting entirely with an estimated $455K sold.
- 28 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q3 2024, down from 38 in Q2 2024.
- Funds reported $17.6M of NovaBridge Biosciences American Depositary Shares stock for Q3 2024, down 31% quarter-over-quarter.
- 3 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q3 2024 and 13 closed out, a net change of -10 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q3 2024 was Caligan Partners, an estimated $156K added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q3 2024 was GSA Capital Partners, an estimated $455K sold.
Based on aggregated 13F filings for Q3 2024.